I don't think US groups used a different type of CBD. As said in the ann, DEA only regulates that CBD used in US needed to be from a different supplier from Oz's.
Actually, the CBD used in US demonstrated comparable good results to Oz's (inflammatory lesions: 40.4% reduction in the USA versus a 40.8% reduction in Australia). The problem is in their combined vehicle group which showed an abnormally high reduction in lesions as well. What @frisbeehead says makes sense - something wrong with the assignment of vehicles and drugs
US Placebo Results Don't Seem Possible, page-17
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.020(6.25%) |
Mkt cap ! $615.4M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 34.0¢ | 32.0¢ | $1.776M | 5.339M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 118187 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 698385 | 8 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |